Genetic Variants in GCKR and Circulating FGF21 as Indicators of Metabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease

• by Asmaa Mohamed Fteah, Doaa Mamdouh Aly, Mohamed A. Elrefaiy, Ali Abdel Rahim

• April 13, 2026

Dietary patterns, metabolic pathways and metainflammation in hidradenitis suppurativa: a systematic review

• by Ezgi Celik, Falk G. Bechara, Eggert Stockfleth, Lennart Ocker-Serger, Nessr Abu Rached

• May 18, 2026

Associations between prevalent unhealthy lifestyles and the gut microbiota: a comprehensive multi-database bibliometric analysis of pathogenic mechanisms and clinical trajectories

• by Xiao-Jie Zhou, Jun-Lei Chen, Chen-Feng Hu, Zhang-Kai Li, Hong-Bo Zheng, Tu-Nan Ding, Yan Chen, Yan Zhu, Jia-Ni Li, Qiang Fu, Yin Fu

• May 12, 2026

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.

• by Latonya Fore-Williams, Michele Distler

• May 13, 2026

• 13 min